Holds one active US DMF for nateglinide, filing since 2013. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Holds 2 active US DMFs for nateglinide, filing since 2007. Its 2020 FDA inspection closed as NAI, and its GMP is recognised in 15 markets.
Holds one active US DMF for nateglinide, filing since 2004. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF for nateglinide, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 9 markets.
Holds one valid CEP for nateglinide, filing since 2024. Its 2026 FDA inspection closed as VAI, and its GMP is recognised in 13 markets.
Holds one active US DMF for nateglinide, filing since 2022. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free